Wanhai Medical Equipment
Self-injection systems and pen injector medical devices
About Wanhai Medical Equipment
Jiangsu Wanhai Medical Equipment Co., Ltd. is a developer and manufacturer of self-medical injection system solutions, founded in 2016 and based in Changzhou, China. The company, led by Chairman and General Manager Luo Lairong, specializes in the research, development, manufacturing, and sales of reusable and disposable pen injectors and auto-injectors. These devices are designed for the self-administration of medications for various chronic conditions, including diabetes, growth disorders, and obesity.
Wanhai Medical's product portfolio includes disposable and reusable pen injectors, as well as auto-injectors compatible with prefilled syringes. The products are used for administering insulin, GLP-1 agonists (such as Liraglutide and Semaglutide), human growth hormone (HGH), and monoclonal antibodies. The business operates on a B2B model, supplying its devices to pharmaceutical and biotechnology companies. It offers customization services for its clients, including packaging design, branding, and color schemes. The company controls the entire production process, from mold design and manufacturing to plastic injection and final assembly in cleanroom environments.
Since its establishment, Wanhai Medical has expanded its operations globally, serving over 180 clients in more than 60 countries. The company has received CE and ISO 13485 certifications and holds over 50 patents. In March 2025, Wanhai Medical secured an RMB 100 million A-round financing from IDG Capital. The company is expanding its production capacity, with a new 36,000-square-meter facility under construction to supplement its existing 12,000-square-meter plant. This expansion aims to increase its annual production capacity from 90 million to 400 million units, supported by the implementation of intelligent fully automated assembly and inspection lines.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 21.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Diabetes, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Mar 2025 | $14M | $55M | IDG Capital | ↗ |
Growth signals
Latest recorded traffic for Wanhai Medical Equipment is 790 monthly website visits, up 507.7% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Wanhai Medical Equipment in its local ecosystem
The Wanhai Medical Equipment office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Wanhai Medical Equipment on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Wanhai Medical Equipment’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









